Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Activist lawyer Wolosky sues Williams Cos over poison pill

Stock MarketsAug 28, 2020 07:50PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. The boardroom is seen during the grand opening and media preview of the new Apple Carnegie Library store in Washington

By Svea Herbst-Bayliss

BOSTON (Reuters) - Lawyer Steve Wolosky usually helps activist investors like Starboard Value take on corporate America. Now he is taking center stage himself, wading into a governance fight over a tool that limits how much stock unwanted investors can buy.

Wolosky is suing Williams Cos (N:WMB) five months after the energy company adopted a so-called poison pill, a takeover defense tool designed nearly 40 years ago to keep hostile bidders and activist investors at bay.

Wolosky filed the proposed class action suit in Delaware Chancery Court this week not on behalf of a client but as the plaintiff himself to force Williams to eliminate "an extremely aggressive overreach of corporate power."

Williams, like dozens of other companies, raced to adopt poison pills as protective measures when their stock prices cratered along with oil prices and fuel demand this year during the COVID-19 pandemic.

But Williams' pill raised eyebrows from the beginning with its unusually low 5% threshold and a "wolfpack" provision aimed at preventing investors from contacting other similarly minded shareholders, governance experts said.

Wolosky's suit says the pill, designed to be in place until March 20, 2021, serves no purpose now. Although Williams' stock tumbled to $9.25 in March and lost half its value in the sell-off, it recovered and closed at $21.07 on Friday. The threat, Wolosky says "has long since evaporated and the continued existence of the Pill can only be for entrenchment purposes."

Williams said on Friday that it stands by its decision to adopt the pill.

"During a time of unprecedented dislocation in equity market valuations, the board acted to support the rights of shareholders and maintain a fair value for their investment, protecting against those who would seek short-term gains to take advantage of market conditions at the expense of the company and its long-term investors," according to an email from Williams Media Relations.

Corporate governance experts said it is highly unusual for a corporate advisor like a lawyer to take this kind of action.

"I don't know of a precedent for this, but that Steve Wolosky himself is the plaintiff only adds gravitas," said Chris Cernich, managing partner at Strategic Governance Advisors, which advises companies facing activists.

Poison pills are generally frowned upon in the governance arena for their dilutive effect on ownership and had been used sparingly, reserved as emergency measures. But this year's volatile markets brought them back.

Proxy advisory firm Institutional Shareholder Services recommended in April that Williams shareholders not support the company's board chair because of the "highly restrictive" nature of the pill.

"There is great controversy around pills and they require careful analysis and crafting to make sure they are not overly restrictive," said Greg Taxin, managing director at Spotlight Advisors, the leading adviser to companies and investors in activist situations, according to FactSet Research Systems.

Wolosky, a partner at Olshan Frome Wolosky, is being represented by Bernstein Litowitz Berger & Grossman LLP and Friedman Oster Tejtel PLLC.

Activist lawyer Wolosky sues Williams Cos over poison pill

Related Articles

Bitcoin falls 8.4% to $49,228.82
Bitcoin falls 8.4% to $49,228.82 By Reuters - Dec 04, 2021

(Reuters) - Bitcoin dropped 8.4% to $49,228.82 at 20:01 GMT on Saturday, losing $4,514.87 from its previous close. Bitcoin, the world's biggest and best-known cryptocurrency, is...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email